Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 3, 2025

Study Completion Date

April 25, 2025

Conditions
Transitional Cell Bladder CancerCystectomyRadiation
Interventions
OTHER

Radical cystectomy with pelvic lymphadenectomy

"Gtoup A : Radical cystectomy group Radical cystectomy included surgical removal of the bladder, adjacent organs, and regional lymph nodes. In males, it included removal of urinary bladder, prostate, and seminal vesicles whereas in females, it included removal of urinary bladder and reproductive organs (ovaries, fallopian tubes, uterus, and anterior vagina).~Standard pelvic lymph node dissection was performed to all patients in this group."

RADIATION

Trimodal therapy

"Group B : trimodal therapy group~the patients underwent maximal TURBT, where as much tumor as possible was completely resected using bipolar resectoscope. The goal was to remove all visible tumor including the underlying muscle layer and tumor edges.~This was followed by radio-sensitizing chemotherapy and radiotherapy..~Chemotherapy consisted of weekly administration of iv infusion of cisplatin (40mg/m2).~Radiotherapy delivered as EBRT aimed at delivering approximately 44- 46 Gy to the urinary bladder and pelvic lymphnodes.followed by additional boost to the bladder 54 GY and a final boost to the tumor 64-65 GY"

Trial Locations (1)

Unknown

AIn shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT07043790 - Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma | Biotech Hunter | Biotech Hunter